BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 26.35
+0.35 (1.35%)
At close: Jul 9, 2026
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 3.28 billion as of July 9, 2026. Its market cap has decreased by -14.52% in one year.
Market Cap
3.28B
Enterprise Value
2.43B
Revenue
229.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.35
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.28B, an increase of 20.73%. That is a compound annual growth rate of 2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.28B | -31.38% |
| Dec 31, 2025 | 4.78B | 14.21% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.74B |
| Formosa Pharmaceuticals | 3.67B |
| Sagittarius Life Science | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.36B |
| Shine-On BioMedical | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.10B |
| Apex Biotechnology | 3.03B |
| 3D Global Biotech | 2.97B |